File(s) not publicly available
Pyrazole derivatives for treating conditions mediated by activation of the adenosine a2b or a3 receptor
standard
posted on 2023-06-08, 19:52 authored by Graham Charles Bloomfield, Catherine Leblanc, Clive McCarthy, Neil John PressCompounds of formula (I) in free or salt form, wherein R1, R2, R3 and R4 have the meanings as indicated in the specification, are useful for treating a condition mediated by activation of the adenosine Alb receptor or the adenosine A3 receptor, particularly an inflammatory or obstructive airways disease. Pharmaceutical compositions that contain the compounds and processes for preparing the compounds are also described.
History
Publication status
- Published
Journal
Br J PharmacolVolume
165Page range
978-993Department affiliated with
- Chemistry Publications
Full text available
- No
Legacy Posted Date
2015-06-02Usage metrics
Categories
No categories selectedKeywords
Licence
Exports
RefWorks
BibTeX
Ref. manager
Endnote
DataCite
NLM
DC